InvestorsHub Logo
icon url

Churchill54

11/09/20 2:47 PM

#11336 RE: Ganz #11335

I think that report is irrelevant at this point. Everything now depends on the approval. We will continue to go sideways albeit slightly lower after DES until the FDA makes their decision. I can’t think of a single reason why Voc wouldn’t be approved but you never know.
icon url

biotech_researcher

11/09/20 4:36 PM

#11339 RE: Ganz #11335

Ganz, it is what you posted:

“Great point church, I totally agree, just depends how it plays out.I hope we hold out for approval and distribution, ******but a savvy big cap Pharma, would have tremendous leverage offering a price before FDA approval*****. I hope, when that happens, AUPH refrains.”